2024
Successful Investigational Phage Therapy for Pan-Resistant Bacterial Mediastinitis Following Type II Hybrid Aortic Arch Replacement
Hameed I, Ahmed A, Gandhi S, Nassiri N, Steinbacher D, Vallabhajosyula P. Successful Investigational Phage Therapy for Pan-Resistant Bacterial Mediastinitis Following Type II Hybrid Aortic Arch Replacement. JACC Case Reports 2024, 29: 102816. PMID: 39691337, PMCID: PMC11646902, DOI: 10.1016/j.jaccas.2024.102816.Peer-Reviewed Original ResearchSternal wound infectionWound infectionPhage therapyStanford type B aortic dissectionThoracic endovascular aortic repairType B aortic dissectionMediastinal wound infectionsAortic arch surgeryAortic arch replacementDelayed sternal closureEndovascular aortic repairHybrid arch repairB aortic dissectionHybrid aortic arch replacementBacterial mediastinitisArch repairArch replacementArch surgeryAortic repairCardiac surgeryMediastinal drainsIntraoperative courseFlap reconstructionMorbid complicationSternal closure
2013
Type I and Type II hybrid aortic arch replacement: postoperative and mid-term outcome analysis.
Vallabhajosyula P, Szeto W, Desai N, Bavaria JE. Type I and Type II hybrid aortic arch replacement: postoperative and mid-term outcome analysis. Annals Of Cardiothoracic Surgery 2013, 2: 280-7. PMID: 23977595, PMCID: PMC3741847, DOI: 10.3978/j.issn.2225-319x.2013.05.09.Peer-Reviewed Original ResearchHybrid aortic arch replacementAortic arch replacementThoracic endovascular repairArch vessel debranchingArch replacementArch aneurysmAverage cardiopulmonary bypass timeAortic arch surgeryAortic reoperation ratesGreater comorbid burdenHybrid arch techniquesPrimary aortic pathologyCardiopulmonary bypass timeHybrid arch repairAortic arch aneurysmCirculatory arrest timeRenal failure rateSafe treatment modalityReoperative cardiac surgeryType IType III patientsType III repairType II repairArch dissectionArch surgery